Orthopaedics

UK hip surgeon Jon Conroy thinks Lady Gaga’s imminent surgery will help raise the worldwide profile of pioneering minimally invasive hip surgery.

Yet again it’s registry data that has provoked a recall, this time of DePuy’s erstwhile Adept modular femoral component, which forms part of the all metal system originally sourced from Finsbury Orthopaedics Ltd.

Scandinavian medtech company Bonesupport is an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic surgery. The company has announced that the next generation product of the CERAMENT™ family, CERAMENT™|G has received CE-mark.

According to a new report , published in “Value in Health”, delaying Total Hip Replacement surgery in people with osteoarthritis as a way to cut costs is ineffective and denies patients the benefits of an active and healthy life.

Even without the revenue following the acquisition of DePuy’s trauma business, Biomet’s SET products showed impressive double digit growth. Joints nudged up too, but it’s SET that has underpinned the company’s positive sales momentum.

Collaborative research performed between the Universities of Edinburgh and Southampton has resulted in a material that combines a plastic scaffold with the potential for stem cell regeneration of bone. It’s hoped the development may result in an expanded ability to repair bone in the most traumatic fracture cases involving bone loss.

Planmed Verity® is designed to find subtle extremity fractures at the first visit to the clinic – fractures that have been the most commonly missed using only 2D radiographs. Now the device is available for sale in USA too.

Stanmore Implants has received 510(k) clearance from the US FDA to market its Sculptor Robotic Guidance Arm™ for precision implant placement in unicompartmental knee surgery, also known as partial knee resurfacing.

Breg says patients really like the comfort of its new T Scope Premier post-op knee brace, particularly with the new incision pad.

Update on proceedings between “vasculopath” Loren Kransky and J&J (DePuy), centring on whether the company poisoned the plaintiff.

Arthroscopy and surgery of the meniscus has evolved gently, in contrast to the radical sea-changes that have occurred in coronary artery interventions. Maybe there hasn’t been enough focus, and perhaps this week’s second international meniscus symposium will change that.

DePuy staff are still sounding defiant, but it’s not looking like the engineering group looked under every rock in establishing the safety and longevity of their ASR device. And then, when warned of issues, the claim is that the company didn’t act quickly enough.

More coverage from the trial between Kransky and DePuy has the all-metal hip maker feeling the heat from revelations that it hid the building concerns of orthopaedic surgeons about its device for a long time before the eventual recall.

Growth in HA viscosupplementation will be driven by rising Global rates of osteoarthritis and obesity, according to a Millennium Research Group report. The company says the market could reach $2.5Bn by 2017.

Zimmer Holdings, Inc. has introduced the Zimmer V2F Anterior Fixation System, a new implant system for the treatment of thoracolumbar burst fractures, tumors, disc degeneration and other pathologies of the anterior spine. The system represents Zimmer’s first lateral plate system for the spinal trauma segment.

We’re loving the number of really clever devices coming before us at the moment. This really smart device for performing distal radius fracture fixation in a minimally invasive manner is a case in point.